Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 1;96(1):32.
doi: 10.1186/s42506-021-00096-9.

A semi-systematic review on hypertension and dyslipidemia care in Egypt-highlighting evidence gaps and recommendations for better patient outcomes

Ashraf Reda  1 , Hany Ragy  2 , Kanwal Saeed  3 , Mohammed Ashraf Alhussaini  4
Affiliations
Review

A semi-systematic review on hypertension and dyslipidemia care in Egypt-highlighting evidence gaps and recommendations for better patient outcomes

Ashraf Reda et al. J Egypt Public Health Assoc. .

Abstract

Background: Both hypertension and dyslipidemia are considered as major modifiable risk factors of cardiovascular diseases (CVDs), and their prevalence in Egypt has increased in recent years. Evidence-based systematic evaluation of data on hypertension and dyslipidemia is critical for effective patient-centric management to reduce the overall risk of CVDs in Egypt. This semi-systematic review aimed to quantify and identify data gaps in the prevalence and distribution of patient journey touchpoints including awareness, screening, diagnosis, treatment, adherence, and control of hypertension and dyslipidemia to provide the basis for research prioritization, practice guidance, and health care reforms in Egypt.

Main body: Structured search was conducted on MEDLINE and Embase to identify articles published in English between January 2010 and December 2019 that reported key patient journey touchpoints in hypertension and dyslipidemia management. Unstructured search was conducted on public or government websites with no date restriction. Data from all sources were extracted and presented descriptively. In total, 22 studies published between 1995 and 2020 on hypertension and dyslipidemia were included in the final analyses. The prevalence of hypertension in Egypt ranged from 12.1 to 59%. Studies reported awareness (37.5% and 43.9%), diagnosis (42% and 64.7%), treatment (24% and 54.1%), and adherence to antihypertensive medication (51.9%) to be low. Furthermore, the percentage of patients who had their blood pressure controlled ranged from 8 to 53.2%. The prevalence of dyslipidemia varied in the general population (range 19.2-36.8%) but was higher in patients with acute coronary syndrome (ACS) (50.9% and 52.5%) and coronary artery disease (58.7%). A national report indicated that 8.6% of the general population was screened for dyslipidemia; however, no data was available on the diagnosis and treatment rates. Among ACS patients, 73.9% were treated for dyslipidemia. Data indicated low levels of medication adherence (59%) among dyslipidemia patients, with overall low control rates ranging from 5.1 to 34.4% depending on CVD risk in populations including ACS patients.

Conclusion: Data on patient journey touchpoints of hypertension and dyslipidemia are limited in Egypt, indicating the need for more systematic and high-quality evidence-based studies covering different aspects of patient-centric management for better management of CVD and its risk factors.

Keywords: Cardiovascular disease; Dyslipidemia; Egypt; Hypertension; Patient-centric; Prevalence; Touchpoints.

PubMed Disclaimer

Conflict of interest statement

AR and HR declare that they have no competing interests. KS is employed in Pfizer Upjohn and MA is employed in Viatris.

Figures

Fig. 1
Fig. 1
Flowchart of literature search results on hypertension. IPD, Incidence and Prevalence Databases; MOH, Ministry of Health; WHO, World Health Organization
Fig. 2
Fig. 2
Flowchart of literature search results on dyslipidemia. IPD, Incidence and Prevalence Databases; MOH, Ministry of Health; WHO, World Health Organization
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Collaborators. G 2019 D and I Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi: 10.1016/S0140-6736(20)30925-910258. - DOI - PMC - PubMed
    1. WHO . Noncommunicable diseases. 2019.
    1. McAloon CJ, Boylan LM, Hamborg T, Stallard N, Osman F, Lim PB, et al. The changing face of cardiovascular disease 2000–2012: An analysis of the world health organisation global health estimates data. Int J Cardiol. 2016;224:256–264. doi: 10.1016/j.ijcard.2016.09.026. - DOI - PubMed
    1. Bovet P, Paccaud F. Cardiovascular disease and the changing face of global public health: a focus on low and middle income countries. Public Health Rev. 2011;33(2):397–415. doi: 10.1007/bf033916432. - DOI
    1. Attia I . Country report Egypt-– Structure of health care in Egypt. 2014.

LinkOut - more resources